Synergy in Mental Health Care: Strengthening Collaborations in a Shared Care System for Child and Adolescent Psychiatry (DSPPea34). (SYNERGIE)

February 17, 2026 updated by: University Hospital, Montpellier

DSPPea34 (Shared Care Program for Children and Adolescents) is an experimental health program designed to provide rapid, guided care orientation for youth aged 6-18 when a first-line psychological follow-up is considered by a general practitioner or pediatrician. The program links hospital-based services and community providers by offering prompt contact and assessment by a registered nurse and/or psychiatrist, with structured feedback to the referring physician.

Primary objective: To identify facilitators that support the engagement of all professionals involved in the care pathway of children and adolescents with psychological difficulties. Facilitators will be mapped across five stages of the pathway: (1) intake, (2) assessment, (3) orientation/referral, (4) inter-partner collaboration, and (5) discharge from the program. Results will be used to refine DSPPea34 specifications to inform broader implementation.

Methods and study population (primary objective): A Delphi survey will be conducted with stakeholders directly interacting with families and youth within DSPPea34 (e.g., general practitioners (GP), pediatricians, program clinicians) as well as with program users.

Secondary objectives and data sources: To describe (i) the sociodemographic and clinical characteristics of youth using DSPPea34 services and (ii) their care trajectories using quantitative methods. Data will be extracted from DSPPea34 records via the SPICO coordination file (the tool used to facilitate exchanges between the GP/pediatrician, DSPPea34, and the psychologist in charge of follow-up) and complemented by soliciting longitudinal outcome information from the referring physician based on DSPPea34 follow-up.

Findings from this mixed-methods evaluation are expected to guide the optimization and potential scale-up of the DSPPea34 model.

Study Overview

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Hérault
      • Montpellier, Hérault, France
        • CHU Montpellier - Réseau DSPPea34 de l'Hérault
        • Contact:
          • Diane PURPER OUAKIL, MD PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

the population of this study (participants responding to the DELPHI questionnaire) includes professionals directly in contact with families and young people within the framework of DSPPea34 as well as users of DSPPea34.

  • the pediatricians or general practitioners who have referred a child or adolescent to the DSPPea34
  • the hospital and private psychiatrist doctors who conducted an initial assessment as part of the DSPPea34
  • the city psychologists who are partners of the program having followed at least one child or adolescent within the framework of the DSPPea34
  • the Coordination Nurse (IDC) of DSPPea34
  • users (legal guardians and young beneficiaries of the care pathway of DSPPea34)

Description

Inclusion Criteria:

  • the professionals directly in contact with families or young people within the framework of DSPPea34 as well as users of DSPPea34

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
the professionals directly in contact with families and young people within the framework of DSPPea3

A structured, online Delphi survey conducted in up to three iterative rounds to co-develop and refine proposals related to the DSPPea34 specifications. Questionnaires are developed by study facilitators based on the initial DSPPea34 specifications and new proposals arising from the interim evaluation.

Content and Response Format:

Each round includes closed-ended items rated on a 9-point Likert scale (1 = strongly disagree; 9 = strongly agree) assessing both the content and the wording of each proposal.

Free-text fields allow participants to provide comments and suggested rewording.

Iterative Adaptation Across Rounds:

Based on prior-round results, items may be revised, added, or removed. Refinements aim to improve clarity and relevance, while preserving traceability of changes.

Consensus Rule (Stopping/Exclusion Criterion for Items):

If an item achieves ≥70% agreement (to retain or to remove the proposal) with concordant votes in both Round 1 and Round 2, the proposal is considered

users of the DSPPea34

A structured, online Delphi survey conducted in up to three iterative rounds to co-develop and refine proposals related to the DSPPea34 specifications. Questionnaires are developed by study facilitators based on the initial DSPPea34 specifications and new proposals arising from the interim evaluation.

Content and Response Format:

Each round includes closed-ended items rated on a 9-point Likert scale (1 = strongly disagree; 9 = strongly agree) assessing both the content and the wording of each proposal.

Free-text fields allow participants to provide comments and suggested rewording.

Iterative Adaptation Across Rounds:

Based on prior-round results, items may be revised, added, or removed. Refinements aim to improve clarity and relevance, while preserving traceability of changes.

Consensus Rule (Stopping/Exclusion Criterion for Items):

If an item achieves ≥70% agreement (to retain or to remove the proposal) with concordant votes in both Round 1 and Round 2, the proposal is considered

Data collected from all users of the DSPPea34 program since its inception (approximately 1,200 cases) will include:

  • sociodemographic data (age, gender, living environment (urban, semi-urban, rural)
  • diagnosis at the end of the initial psychiatric assessment of the DSPPea34 program
  • referring physician
  • schooling (grade, mainstream or specialized environment)
  • existence of previous psychiatric or psychological follow-up
  • referrals by DSPPea34 staff and reasons (without collection of individual data for young people not included in DSPPea34 at the end of the staff meeting)
  • referrals at the end of the medical consultation and reasons
  • end-of-process referrals.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Highlighting by the DELPHI method of the main facilitators of involvement in the DSPPea34 pathway, from successive rounds of proposal prioritization
Time Frame: 3 months

These facilitators will be identified at different stages: 1) addressing, 2) evaluation, 3) orientation, 4) collaboration between partners, 5) exit from the device and will allow to evolve the specifications of DSPPea in view of its generalization.

Each round includes closed-ended items rated on a 9-point Likert scale (1 = strongly disagree; 9 = strongly agree) assessing both the content and the wording of each proposal. Free-text fields allow participants to provide comments and suggested rewording. Iterative Adaptation Across Rounds: Based on prior-round results, items may be revised, added, or removed. Refinements aim to improve clarity and relevance, while preserving traceability of changes. Consensus Rule (Stopping/Exclusion Criterion for Items): If an item achieves ≥70% agreement (to retain or to remove the proposal) with concordant votes in both Round 1 and Round 2, the proposal is considered

3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Characterization at Baseline
Time Frame: At program entry (Baseline)
Clinical profile including reason for referral, prior or ongoing mental-health follow-up, and functioning assessment coded as ICD-11 diagnostic categories and Children's Global Assessment
At program entry (Baseline)
Reason for referral to the program
Time Frame: Baseline
Proportion of patients according to broad categories of referral reasons Unit of Measure: % of participants.
Baseline
Number of Requests and Referrals (DSPPea34 vs. Outside DSPPea34)
Time Frame: Baseline
Count of requests and final referral directions (within DSPPea34 or redirected outside DSPPea34).
Baseline
Number of Psychiatric Clinical Interviews within DSPPea34
Time Frame: At program entry (intake) to program completion (from 1 month to 12 months)
Total number of psychiatric clinical interviews conducted as part of DSPPea34.
At program entry (intake) to program completion (from 1 month to 12 months)
Number of Joint City-Hospital Follow-Ups
Time Frame: At program entry (intake) to program completion (from 1 month to 12 months)
Count of joint follow-up episodes involving community (city) providers and hospital-based teams.
At program entry (intake) to program completion (from 1 month to 12 months)
Number of Follow-Ups Coordinated by Primary Care
Time Frame: At program entry (intake) to program completion (from 1 month to 12 months)
Count of follow-up episodes coordinated by primary care actors (e.g., GP or pediatrician).
At program entry (intake) to program completion (from 1 month to 12 months)
Youth Status at Program Exit
Time Frame: At program entry (intake) to program completion (from 1 month to 12 months)
Disposition at discharge (e.g., type of ongoing follow-up, referral destination) and youth outcome at exit
At program entry (intake) to program completion (from 1 month to 12 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Diane PURPER OUAKIL, MD PhD, CHU de Montpellier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

February 3, 2026

First Submitted That Met QC Criteria

February 17, 2026

First Posted (Actual)

February 24, 2026

Study Record Updates

Last Update Posted (Actual)

February 24, 2026

Last Update Submitted That Met QC Criteria

February 17, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RECHMPL24_0352

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on structured online questionnaire

Subscribe